Cytolytic T lymphocyte responses of cancer patients to tumor-associated antigens

Springer Seminars in Immunopathology

Volumn 18, Issue 2, 1996, Pages 185-198

  Romero, Pedro ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

CANCER PATIENT; CYTOTOXIC T LYMPHOCYTE; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY;

ANTIGENS, NEOPLASM; HUMANS; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029811969     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00820665     Document Type: Review

References (79)

1. Adema GJ, Boer AJ de, Hullenaar R van't, Denijn M, Ruiter DJ, Vogel AM, Figdor CG (1993) Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Pathol 143: 1579
2. Adema GJ, Boer AJ de, Vogel AM, Loenen WAM, Figdor CG (1994) Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem 269: 20 126
3. Anjuère F, Layer A, Cerottini JC, Servis C, Luescher IF (1995) Synthesis of a radioiodinated photoreactive MAGE-1 peptide derivative and photoaffinity labeling of cell-associated human leukocyte antigen-A1 molecules. Anal Biochem 229: 61
4. Bakker ABH, Schreurs MWJ, Boer AJ de, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG (1994) Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 179: 1005
5. Berchuk A, Kamel A, Whitaker R, Kerns B, Olti G, Kinney R, Soper J, Dodge R, Clarke-Pearson D, Marks P (1990) Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50: 4087
6. Bilbe G, Delabie J, Bruggen J, Richener H, Asselbergs FA, Cerletti N, Sorg C, Odink K, Tarcsay L, Weisendanger W (1992) Restin: a novel intermediate filament-associated protein highly expressed in the Reed-Sternberg cells of Hodgkin's disease. EMBO J 11: 2103
7. Boel P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T, Bruggen P van der (1995) BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2: 167
8. Boon T, Cerottini JC, Van den Eynde B, Bruggen P van der, Van Pel A (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12: 337
9. Brasseur F, Marchand M, Vanwijck R, Herin M, Leté B, Chomez P, Boon T (1992) Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer 52: 839
10. Brasseur F, Rimoldi D, Liénard D, Lethé B, Carrel S, Arienti F, Suter L, Vanwijck R, Bourlond A, Humblet Y, Vacca A, Conese M, Lahaye T, Degiovanni G, Deraemaecker R, Beauduin M, Sastre X, Salamon E, Dréno B, Jäger E et al (1995) Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 63: 375
11. Brichard VG, Herman J, Wildmann C, Gaugler B, Wölfel T, Boon T, Lethé B (1996) A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur J Immunol 26: 224
12. Brichard VG, Van Pel A, Wölfel T, Wölfel C, De Plaen E, Lethé B, Coulie P, Boon T (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178: 489
13. Bruggen P van der, Bastin J, Gajewski T, Coulie P, Boël P, De Smet C, Traversari C, Townsend A, Boon T (1994) A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 24: 3038
14. Bruggen P van der, Szikora JP, Boël P, Wildmann C, Somville M, Sensi M, Boon T (1994) Autologous cytolytic T lymphocytes recognized a MAGE-1 nonapeptide on melanomas expressing HLA-Cw* 1601. Eur J Immunol 24: 2134
15. Bruggen P van der, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643
16. Casanova JL, Cerottini JC, Matthes M, Necker A, Gournier H, Barra C, Widmann C, MacDonald HR, Lemonnier F, Malissen B, Maryanski JL (1992) H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. J Exp Med 176: 439
17. Casanova JL, Romero P, Widmann C, Kourilsky P, Maryanski JL (1991) T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J Exp Med 174: 1371
18. + cytotoxic T lymphocytes. J Exp Med 181: 363
19. Celis E, Tsai V, Crimi C, DeMars R, Wentworth PA, Chesnut RW, Grey HM, Sette A, Serra HM (1994) Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci USA 91: 2105
20. Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W (1995) Immunity to oncogenic proteins. Immunol Rev 145: 33
21. Chen YT, Stockert E, Tsang S, Coplan KA, Old LJ (1995) Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc Natl Acad Sci USA 92: 8125
22. Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora JP, Renauld JC, Boon T (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180: 35
23. Coulie PG, Lehmann F, Lethé B, Herman J, Lurquin C, Andrawiss M, Boon T (1995) A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 92: 7976
24. Coussens L, Yang-Feng TL, Chen YLE, Grey A, McGrath J, Seeburg PH, Liberman TA, Schlessinger J, Francke U, Levinson A, Ullrich A (1985) Tyrosinase kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132
25. Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL Jr (1994) Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264: 716
26. De Plaen E, Arden K, Traversari C, Galforio JJ, Szikora JP, De Smet C, Brasseur F, Bruggen P van der, Lethe B, Lurquin C, Brasseur R, Chomez P, Backer O de, Cazenave W, Boon T (1994) Structure, chromosomal localization and expression of 12 genes of the MAGE family. Immunogenetics 40: 360
27. Disis ML, Calenoff E, McLaughlin G, Murphy AE, Chen W, Groner B, Jeschke M, Lydon N, McGlynn E, Livingston RB, Moe R, Cheever MA (1994) Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res 54: 16
28. Engelhard VH (1994) Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol 12: 181
29. Fisk B, Blevins TL, Wharton JT, Ioannides CG (1995) Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J Exp Med 181: 2109
30. Gaugler B, Van den Eynde B, Bruggen P van der, Romero P, Gaforio JJ, De Plaen E, Lethé B, Brasseur F, Boon T (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lympocytes. J Exp Med 179: 921
31. 30a. Gaugler B, Brouwenstijn N, Vantomme V, Szikora J-P, Van der Spek C, Patard J-J, Boon T, Schrier, Van den Eynde B (1996) A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics (in press)
32. Gonzalez-Quintial R, Baccala R, Pope RM, Theofilopoulos AN (1996) Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. J Clin Invest 97: 1335
33. Guilloux Y, Lucas S, Brichard VG, Van Pel A, Viret C, De Plaen E, Brasseur F, Lethé B, Jotereau F, Boon T (1996) A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J Exp Med 183: 1173
34. Herman J, Bruggen P van der, Luescher IF, Mandruzzato S, Romero P, Thonnard J, Fleischhauer K, Boon T, Coulie PG (1996) A peptide encoded by the human MAGE-3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics 43: 377
35. Hoon DS, Yuzuki D, Hayashida M, Morton DL (1995) Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J Immunol 154: 730
36. Inoue H, Mori M, Honda M, Li J, Shibuta K, Mimori K, Ueo H, Akiyoshi T (1995) The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma. J Exp Med 174: 1371
37. Jäger E, Bernhard H, Romero P, Ringhoffer M, Arand M, Karbach J, Ilsemann C, Hagedorn M, Knuth A (1996) Generation of cytotoxic T cell responses with synthetic melanoma associated peptides in vivo, implications for tumor vaccines with melanoma associated antigens. Int J Cancer 66:162
38. Kang X, Kawakami Y, El-Gamil M, Wand R, Sakaguchi K, Yannelli JR, Appella E, Rosenberg SA, Robbins PF (1995) Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J Immunol 155: 1343
39. Kawakami Y, Eliyahu S, Jennings C, Sakaguchi K, Kang X, Southwood S, Robbins PF, Sette A, Appella E, Rosenberg SA (1995) Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 154: 3961
40. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E, Rosenberg SA (1994) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180: 347
41. neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 50: 5184
42. Kobayashi T, Urabe K, Winder A, Jimenez-Cervantes C, Imokawa G, Brewington T, Solano F, Garcia-Borron JC, Hearing VJ (1994) Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 13: 5818
43. Kwon BS, Chintamanemi C, Kozak CA, Copeland NG, Gilbert DJ, Jenkins N, Barton D, Francke U, Kobayashi Y, Kim KK (1991) A melanocyte-specific gene,Pmel17, maps near the silver coat color locus on mouse chromosome 10 and is a synthenic region on human chromosome 12. Proc Natl Acad Sci USA 88: 9228
44. Levraud JP, Pannetier C, Langlade-Demoyen P, Brichard V, Kourilsky P (1996) Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the P815 murine tumor. J Exp Med 183: 439
45. Linsley PS and Ledbetter JA (1993) The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11: 191
46. Luescher IF, Romero P, Kuznetsov D, Rimoldi D, Coulie P, Cerottini JC, Jongeneel CV (1996) HLA photoaffinity labeling reveals overlapping binding of homologous MAGE peptides by HLA-A1,HLA-29 and HLA-B44. J Biol Chem 271:12463
47. Mueller DL, Jenkins MK, Schwartz RH (1989) Clonal expansion versus clonal inactivation: a costimulatory pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7: 445
48. Mulcahy KA, Rimoldi D, Brasseur F, Rodgers S, Liénard D, Marchand M, Rennie IG, Murray AK, McIntyre CA, Platts KE, Leyvraz S, Boon T, Rees RC (1996) Infrequent expression of the MAGE gene family in uveal melanomas. Int J Cancer (in press)
49. Muscatelli F, Walker AP, De Plaen E, Stafford AN, Monaco AP (1995) Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci USA 92: 4987
50. Pannetier C, Even J, Kourilsky P (1995) T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 16: 176
51. Patard JJ, Brasseur F, Gil-Diez S, Radvanyi F, Marchand M, Francois P, Abi Aad A, Van Cangh P, Abbou CC, Chopin D, Boon T (1995) Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer 64: 60
52. Peoples GE, Goedegebuure PS, Smith R, Linehan DC, Yoshino I, Eberlein TJ (1995) Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc Natl Acad Sci USA 92: 432
53. Rimoldi D, Romero P, Carrel S (1993) The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 54: 1
54. Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins PF, Marincola FM, Salgaller ML, Yannelli JR, Appella E, Rosenberg SA (1995) Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J Immunol 154: 2257
55. Robbins PF, El-Gamil M, Kawakami Y, Rosenberg SA (1994) Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 54: 3124
56. Robbins PF, El-Gamil M, Li YF, Kawakami Y, Loftus D, Appella E, Rosenberg SA (1996) A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med 183: 1185
57. Romero P, Eberl G, Casanova JL, Cordey AS, Widmann C, Luescher IF, Corradin G, Maryanski JL (1992) Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. J Immunol 148: 1871
58. Romero P, Pannetier C, Herman J, Jongeneel CV, Cerottini JC, Coulie P (1995) Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1. J Exp Med 182: 1019
59. Russo V, Traversari C, Verrecchia A, Mottolese M, Natali PG, Bordignon C (1995) Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int J Cancer 64: 216
60. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11 810
61. Sensi M, Parmiani G (1995) Analysis of TCR usage in human tumors - a new tool for assessing tumor-specific immune responses. Immunol Today 16: 588
62. Sensi M, Traversari C, Radrizzani M, Salvi S, Maccalli C, Mortarini R, Rivoltini L, Farina C, Nicolini G, Wölfel T, Brichard V, Boon T, Bordignon C, Anichini A, Parmiani G (1995) Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1. Proc Natl Acad Sci USA 92: 5674
63. Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177
64. Thompson JA, Grunert F, Zimmermann W (1991) Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 5: 344
65. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci USA 91: 9461
66. Townsend A and Trowsdale J (1993) The transporters associated with antigen presentation. Semin Cell Biol 4: 53
67. Traversari C, Bruggen P van der, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A, Boon T (1992) A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176: 1453
68. Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J (1995) Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst 87: 982
69. Van den Eynde B, Lethé B, Van Pel A, De Plaen E, Boon T (1991) The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med 173: 1373
70. Van den Eynde B, Peeters O, Backer O de, Gaugler B, Lucas S, Boon T (1995) A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 182: 689
71. Van Pel A, Bruggen P van der, Coulie PG, Brichard VG, Lethé B, Van den Eynde B, Uyttenhove C, Renauld JC, Boon T (1995) Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev 145: 229
72. Vijaysaradhi S, Bouchard B, Houghton AN (1990) The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product. J Exp Med 171: 1375
73. Walter L, Dirks B, Rothermel E, Heyens M, Szoirir C, Levon G, Günther E (1994) A novel, conserved gene of the rat that is developmentally regulated in the testis. Mamm Genome 5: 216
74. Wang RF, Parkhurst MR, Kawakami Y, Robbins PF, Rosenberg SA (1996) Utilization of an alternative open reading frame of a normal gene generating a novel human cancer antigen. J Exp Med 183: 1131
75. Wang RF, Robbins PF, Kawakami Y, Kang XQ, Rosenberg SA (1995) Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor infiltrating lymphocytes. J Exp Med 181: 799
76. Weynants P, Lethé B, Brasseur F, Marchand M, Boon T (1994) Expression of MAGE genes by non-small cell lung carcinomas. Int J Cancer 56: 826
77. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269: 1281
78. Wölfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Büschenfelde KH, Boon T (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 24: 759
79. Yonemura Y, Ninomiya I, Yamaguchi A, Fuchida S, Kimura H, Ohoyama S, Miyazakil I, Endou Y, Tanaka M, Susaki T (1991) Evaluation of immunoreactivity for erb-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 51: 1034